Published on: 03/05/2025 12:25 PM
|
Share your opinion about minimum length requirements for sequence listings in a WIPO survey
The World Intellectual Property Organization (WIPO) is seeking public input regarding the impact of their Standard ST.26 minimum length requirement on patent practice. The USPTO is alerting stakeholders about the survey to assist WIPO in gathering public input.
ST.26 lays out the requirements for presenting nucleotide and/or amino acid sequences in patent applications and prohibits the inclusion of “short” sequences in sequence listings. “Short” sequences are defined as any nucleotide sequence with fewer than 10 specifically defined (non-“n”) residues or any amino acid sequence with fewer than four specifically defined (non-“X”) residues.
The WIPO survey will be open until March 31.
|
|
|
|
|
Having trouble accessing links in this email? Your email server security software may be altering the links. Contact your IT or email administrator and ask them to "allow-list" links-1.govdelivery.com and links-2.govdelivery.com to ensure you can access all content in this communication.
Stay connected with the USPTO by subscribing to regular email updates. Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.
This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.
|
|
|
|
|
|
|
